echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > JCC: CXCR3 ligand can be used as a biomarker for postoperative recurrence in patients with Crohn's disease

    JCC: CXCR3 ligand can be used as a biomarker for postoperative recurrence in patients with Crohn's disease

    • Last Update: 2021-11-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Crohn’s disease (CD) is a chronic inflammatory bowel disease.
    Approximately one-third of CD patients require bowel resection within five years after diagnosis.
    Although the "biological era" has arrived, the surgical rate has dropped significantly.
    But bowel resection is still the main treatment for CD
    .


    Disease recurrence in CD patients usually occurs in the new terminal ileum, and the Rutgeerts score can be used to judge the recurrence, which has been shown to predict important clinical outcomes including clinical recurrence and the need for further surgery


    Crohn’s disease (CD) is a chronic inflammatory bowel disease.


     

    This study included patients with CD who underwent ileocolectomy (ICR) in the final analysis, and serum samples from the patients were obtained during postoperative colonoscopy
    .


    Multiple immunoassays are used to analyze the correlation between 92 Olink Proteomics and CD disease


    immunity

     

    In this study, a total of 276 colonoscopy data were obtained from 213 patients
    .


    The median time from surgery to the first and second colonoscopy was 7 and 19 months, respectively


     

    This study determined that many new candidate protein biomarkers are associated with postoperative recurrence of CD patients, especially the recurrence of CD after ileocolectomy
    .


    Among them, CXCR3 ligand has the most correlation with CD recurrence after ICR


    This study determined that many new candidate protein biomarkers are associated with postoperative recurrence of CD patients, especially the recurrence of CD after ileocolectomy


    Margaret Walshe.


    A role for CXCR3 ligands as biomarkers of post-operative Crohn's disease recurrence.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.